Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: is a proposed colorectal cancer (CRC) predisposition gene, with only four families with putative loss-of-function (pLoF) variants published. The prevalence, phenotypic spectrum, and clinical management recommendations for heterozygotes remain unknown.

Methods: Retrospective review of approximately 950,000 individuals undergoing multigene panel testing (MGPT) for cancer predisposition identified 36 individuals with pLoF variants in . Clinical features, tumor prevalence, and age at onset were compared with Lynch syndrome (LS) and wild-type (WT) cohorts.

Results: Thirty-six individuals (0.004%) had 28 unique pLoF variants in and a total of 42 primary tumors, 78.6% of which were CRC with a median age of diagnosis of 50 years. A total of 16.7% of individuals had multiple CRC primaries, and a majority (71.4%) were mismatch repair-proficient (pMMR). Signet ring cell (SRC) pathology was significantly enriched compared with WT ( = <.0001). The odds ratio for CRC was significantly higher than that for the -related LS cohort (odds ratio [OR], 45.3 [95% CI, 21.3 to 101] and OR, 16.9 [95% CI, 14.9 to 19.2], respectively).

Conclusion: is associated with early-onset, pMMR CRC enriched for SRC pathology. Comparison of prevalence showed a statistically significant two-fold increase in the odds of developing CRC compared with an LS cohort. These data confirm the gene-disease relationship between and CRC and support clinical management guidelines similar to -related LS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406993PMC
http://dx.doi.org/10.1200/PO-25-00214DOI Listing

Publication Analysis

Top Keywords

plof variants
12
colorectal cancer
8
950000 individuals
8
individuals
5
association loss-of-function
4
variants
4
loss-of-function variants
4
variants colorectal
4
cancer risk
4
risk cohort
4

Similar Publications

Background: ANK3 encodes ankyrin-G, a key scaffolding protein essential for neuronal function. While both monoallelic and biallelic ANK3 variants have been linked to neurodevelopmental disorders (NDDs), existing evidence for their pathogenicity and clinical correlation remains limited and heterogeneous.

Objective: To delineate the clinical features associated with biallelic ANK3 predicted loss-of-function (pLOF) variants.

View Article and Find Full Text PDF

Purpose: is a proposed colorectal cancer (CRC) predisposition gene, with only four families with putative loss-of-function (pLoF) variants published. The prevalence, phenotypic spectrum, and clinical management recommendations for heterozygotes remain unknown.

Methods: Retrospective review of approximately 950,000 individuals undergoing multigene panel testing (MGPT) for cancer predisposition identified 36 individuals with pLoF variants in .

View Article and Find Full Text PDF

Background: Cancer predisposition syndromes (CPSs) with pediatric onset are the leading known cause of childhood malignancies and are increasingly guiding clinical strategies in pediatric oncology. CPSs are placed under evolutionary negative selective pressure, but pediatric pancancer studies have so far failed to investigate genomic evolutionary metrics as a guide to predict penetrance and reveal novel CPSs.

Method: Germline whole-genome sequencing (WGS) in a 5-year prospective, registry-validated, nationwide cohort of individuals diagnosed with cancer before 18 years of age.

View Article and Find Full Text PDF

Generation of four human pluripotent stem cell lines harboring OPA1-related optic atrophy variant.

Stem Cell Res

September 2025

Hawaii Permanente Medical Group, Kaiser Permanente, Mapunapuna Medical Office, USA. Electronic address:

We have generated four human iPSC lines from skin biopsy-derived fibroblast cells with pathogenic variants in OPA1. Donors have a clinical diagnosis of optic atrophy. Three harbor heterozygous presumed loss-of-function (pLOF) variants, c.

View Article and Find Full Text PDF

Functional analysis of human EED variants using Drosophila.

Genetics

September 2025

Department of Medical Genetics, University of British Columbia, Life Sciences Institute, The University of British Columbia, 2350 Health Sciences Mall, Vancouver, British Columbia, Canada V6T 1Z3.

The Polycomb Repressive Complex 2 is an epigenetic reader/writer that methylates histone H3K27. Rare germline partial loss-of-function (pLoF) variants in core members of the complex (EZH2, EED, and SUZ12) cause overgrowth and intellectual disability syndromes, whereas somatic variants are implicated in cancer. However, up to 1% of the general population will have a rare variant in one of these genes, most of which would be classified as variants of uncertain significance (VUS).

View Article and Find Full Text PDF